MATERIALISE: Q1 2019 results slightly below estimates; FY19 guidance reiterated | BUY | USD19
MATERIALISE - BUY | USD19Q1 2019 results slightly below estimates; FY19 guidance reiterated
Q1 2019 results slightly below expectations
The Medical division boosted its growth investments
FY19 guidance reiterated, with a better performance for H2
We reiterate our Buy rating and our Fair Value of USD19
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.